Muhlenkamp & Co’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-70,655
| Closed | -$7.02M | – | 39 |
|
|
2019
Q3 | $7.02M | Buy |
70,655
+34
| +0% | +$3.38K | 3.42% | 14 |
|
|
2019
Q2 | $6.53M | Sell |
70,621
-210
| -0.3% | -$19.4K | 3.17% | 15 |
|
|
2019
Q1 | $6.68M | Buy |
+70,831
| New | +$6.68M | 3.17% | 17 |
|
|
2018
Q3 | $6.45M | Sell |
72,116
-377
| -0.5% | -$33.7K | 2.76% | 19 |
|
|
2018
Q2 | $5.76M | Hold |
72,493
| – | – | 2.2% | 23 |
|
|
2018
Q1 | $6.47M | Buy |
72,493
+2,392
| +3% | +$213K | 2.35% | 22 |
|
|
2017
Q4 | $7.32M | Sell |
70,101
-1,354
| -2% | -$141K | 2.16% | 20 |
|
|
2017
Q3 | $10.4M | Sell |
71,455
-963
| -1% | -$140K | 3.28% | 13 |
|
|
2017
Q2 | $9.41M | Sell |
72,418
-75
| -0.1% | -$9.74K | 2.95% | 13 |
|
|
2017
Q1 | $9.02M | Sell |
72,493
-195
| -0.3% | -$24.3K | 2.76% | 15 |
|
|
2016
Q4 | $8.41M | Sell |
72,688
-827
| -1% | -$95.7K | 2.66% | 18 |
|
|
2016
Q3 | $7.69M | Buy |
73,515
+53,706
| +271% | +$5.61M | 2.9% | 15 |
|
|
2016
Q2 | $1.95M | Buy |
+19,809
| New | +$1.95M | 0.76% | 31 |
|
|
2015
Q2 | – | Sell |
-85,540
| Closed | -$9.86M | – | 72 |
|
|
2015
Q1 | $9.86M | Sell |
85,540
-700
| -0.8% | -$80.7K | 2.08% | 25 |
|
|
2014
Q4 | $9.65M | Sell |
86,240
-60,700
| -41% | -$6.79M | 1.93% | 24 |
|
|
2014
Q3 | $13.9M | Buy |
146,940
+2,800
| +2% | +$265K | 2.52% | 16 |
|
|
2014
Q2 | $12.4M | Sell |
144,140
-154,510
| -52% | -$13.3M | 2.18% | 18 |
|
|
2014
Q1 | $20.8M | Buy |
298,650
+3,800
| +1% | +$265K | 3.67% | 7 |
|
|
2013
Q4 | $24.9M | Buy |
294,850
+8,240
| +3% | +$696K | 4.34% | 3 |
|
|
2013
Q3 | $22.1M | Buy |
286,610
+840
| +0.3% | +$64.7K | 4.39% | 4 |
|
|
2013
Q2 | $16.7M | Buy |
+285,770
| New | +$16.7M | 3.48% | 9 |
|